Discussion on how the presence of chronic low-grade neuroinflammation should influence DME treatment decisions. Treatments that suppress chronic low-grade inflammation and subsequent edema can help prevent retinal damage and permanent vision loss.
Discussion on the influence of chronic low-grade inflammation on DME patient clinical outcomes.
Discussion on the role of systemic inflammation in diabetic eye disease and specifically how chronic low-grade inflammation effects the pathophysiology of diabetic macular edema.